Suppr超能文献

摆位不确定性对立体定向放射治疗中分次照射的放射生物学优势的影响。

The effect of setup uncertainties on the radiobiological advantage of fractionation in stereotaxic radiotherapy.

作者信息

Lo Y C, Ling C C, Larson D A

机构信息

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1113-9. doi: 10.1016/0360-3016(95)02179-5.

Abstract

PURPOSE

There may be radiobiological advantages in administering stereotaxic radiation treatment in multiple fractions instead of by a single irradiation. However, a larger planning target volume may be required for fractionated stereotaxic radiotherapy than for a single session treatment, if decreased geometrical precision and increased setup uncertainty are associated with multiple-fraction treatments. This factor may partially offset the radiobiological gain. The purpose of this study is to estimate the potential therapeutic gain of fractionated treatments for brain tumors, and to assess the effect of increased setup uncertainty on the potential gain.

METHODS AND MATERIALS

The concept of biologically effective dose (BED), based on the linear quadratic (LQ) model, was used to quantify the therapeutic efficacy of the respective treatment schema. Therapeutic gain (TG) was defined as the ratio of tumor BEDs, for multiple fractions and single treatment, respectively, for the same normal brain BED. To include the effect of increased planning volume in fractionated treatment, a power-law relationship was assumed for the volume dependence of prescription dose, and the TG was recalculated using the "volume-adjusted" doses.

RESULTS

The therapeutic gain for fractionated treatment increases with fraction number, and is smaller for larger single treatment doses. For example, in going from 1 to 10 fractions, the TG is 1.40, 1.32, or 1.27 for single treatment dose of 20, 30, or 40 Gy, respectively. Also, the TG is more significant for the initial few fractions. The benefit of fractionation is diminished if larger planning volume is needed for multiple fraction treatments. For example, the above TG are reduced to 1.19, 1.11, or 1.06, if a 2 cm planning target volume in single fraction treatment is enlarged to 2.3 cm in fractionated treatment.

CONCLUSION

Consideration of the therapeutic gain with fractionation should include estimates of setup uncertainty for multiple-fraction treatments, relative to that of single fraction radiosurgery.

摘要

目的

与单次照射相比,多次分割进行立体定向放射治疗可能具有放射生物学优势。然而,如果多次分割治疗会导致几何精度降低和摆位不确定性增加,那么与单次治疗相比,分割立体定向放射治疗可能需要更大的计划靶体积。这一因素可能会部分抵消放射生物学益处。本研究的目的是评估脑肿瘤分割治疗的潜在治疗增益,并评估摆位不确定性增加对潜在增益的影响。

方法和材料

基于线性二次(LQ)模型的生物等效剂量(BED)概念,用于量化各治疗方案的治疗效果。治疗增益(TG)定义为在相同正常脑BED条件下,多次分割和单次治疗时肿瘤BED的比值。为了纳入分割治疗中计划靶体积增加的影响,假设处方剂量与体积呈幂律关系,并使用“体积校正”剂量重新计算TG。

结果

分割治疗的治疗增益随分割次数增加而增加,单次治疗剂量越大,治疗增益越小。例如,从1次分割增加到10次分割时,单次治疗剂量为20、30或40 Gy时,TG分别为1.40、1.32或1.27。此外,最初几次分割时TG更显著。如果多次分割治疗需要更大的计划靶体积,分割治疗的益处会减弱。例如,如果单次分割治疗时2 cm的计划靶体积在分割治疗中增大到2.3 cm,上述TG会分别降至1.19、1.11或1.06。

结论

考虑分割治疗的治疗增益时,应包括相对于单次分割放射外科手术的多次分割治疗摆位不确定性的评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验